Global litigation over SEPs is facing new strategies by implementers, mainly related to venue selection. There is an ...
Armond Wilson partners Monica Arnold and Michelle Armond are back with the latest installment of their year-end column ...
While being realistic and practical in IP law is usually prudent, it’s a helpful exercise to now and then articulate one’s ...
Patents Act, 1970 Supreme Court Reports Supreme Court Transfers Eureka Forbes' Patent Infringement Suit Against Atomberg's ...
The Prescription Drug User Fee Act target guidelines for NDA resubmissions include acknowledgment of acceptance for review ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual General Meeting the Board ...
Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients ...
Three-year agreement allows for commercialization of next-generation asset-intelligence technology for manufacturing and ...
Easy Environmental Solutions, Inc. (OTC: EZES) today announced the completed construction and availability of the EasyFEN ...
AllAfrica on MSN
Software Development in Africa: Understanding Code Ownership and the Risks of Imitation
Code drives Africa’s tech surge, powered by a young, digital-native population and growing investment. From Lagos to Nairobi to Cape Town, teams are launching payment, health, and edtech platforms.
Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...
ANGELINA Jolie is in a secret legal battle over her New York City studio as she continues her long-standing, vicious court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results